Russell Investments Group, Ltd. Aerie Pharmaceuticals Inc Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$4.95 - $9.16 $50,455 - $93,367	-10,193 Reduced 15.26%	56,621 $424,000
Q1 2022 May 05, 2022	SELL	$5.64 - $9.8 $101,085 - $175,645	-17,923 Reduced 21.15%	66,814 $607,000
Q4 2021 Jan 21, 2022	SELL	$7.02 - $13.33 $32,720 - $62,131	-4,661 Reduced 5.21%	84,737 $593,000
Q3 2021 Nov 08, 2021	SELL	$11.32 - $16.63 $3,407 - $5,005	-301 Reduced 0.34%	89,398 $1.02 Million
Q2 2021 Aug 04, 2021	BUY	$15.16 - $18.97 $584,069 - $730,857	38,527 Added 75.29%	89,699 $1.44 Million
Q1 2021 May 10, 2021	SELL	$13.12 - $20.9 $686,044 - $1.09 Million	-52,290 Reduced 50.54%	51,172 $914,000
Q4 2020 Feb 08, 2021	BUY	$9.12 - $14.49 $505,129 - $802,557	55,387 Added 115.21%	103,462 $1.4 Million
Q3 2020 Nov 09, 2020	BUY	$10.46 - $14.46 $502,864 - $695,164	48,075 New	48,075 $564,000
Q1 2019 May 13, 2019	SELL	$36.32 - $49.25 $13.7 Million - $18.5 Million	-375,935 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$33.0 - $60.04 $1.15 Million - $2.1 Million	-34,953 Reduced 8.51%	375,935 $13.5 Million
Q3 2018 Oct 26, 2018	BUY	$56.15 - $73.9 $6.38 Million - $8.39 Million	113,598 Added 38.21%	410,888 $25.3 Million
Q2 2018 Aug 08, 2018	BUY	$47.85 - $70.45 $260,016 - $382,825	5,434 Added 1.86%	297,290 $20.1 Million
Q1 2018 May 11, 2018	SELL	$51.15 - $61.0 $2.27 Million - $2.71 Million	-44,346 Reduced 13.19%	291,856 $15.8 Million
Q4 2017 Feb 06, 2018	SELL	$50.85 - $65.1 $2.67 Million - $3.42 Million	-52,464 Reduced 13.5%	336,202 $20.8 Million
Q3 2017 Nov 07, 2017	BUY	$48.6 - $60.1 $18.9 Million - $23.4 Million	388,666	388,666 $18.9 Million

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account